Jordi Bruix
- Hepatology top 0.01%
- Epidemiology top 0.01%
- Surgery top 0.02%
- Cancer Research top 0.02%
- Molecular Biology top 0.2%
- Co-authors
- Josep M. LlovetMorris ShermanAlejandro FornerMaría ReigConcepció BrúAndrew K. BurroughsCarmen AyusoJosep Fuster
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (266 papers)Liver Disease Diagnosis and Treatment (162 papers)Liver Disease and Transplantation (74 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Jordi Bruix
372 papers receiving 73.8k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Hepatology 56.4k
- Epidemiology 34.0k
- Surgery 14.7k
- Cancer Research 12.7k
- Molecular Biology 12.5k
Countries citing papers authored by Jordi Bruix
This map shows the geographic impact of Jordi Bruix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Bruix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Bruix more than expected).
Fields of papers citing papers by Jordi Bruix
This network shows the impact of papers produced by Jordi Bruix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Bruix. The network helps show where Jordi Bruix may publish in the future.
Co-authorship network of co-authors of Jordi Bruix
This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Bruix. A scholar is included among the top collaborators of Jordi Bruix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Bruix. Jordi Bruix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 82 | |
| 3 | 22 | |
| 4 | 28 | |
| 5 | Regorafenib as second-line treatment for patients with HCC who progressed on sorafenib: Japanese subgroup analysis of phase 3 RESORCE trial | 1 |
| 6 | 21 | |
| 7 | 266 | |
| 8 | 44 | |
| 9 | 230 | |
| 10 | 133 | |
| 11 | 1 | |
| 12 | 171 | |
| 13 | 312 | |
| 14 | 222 | |
| 15 | 1 | |
| 16 | 10 | |
| 17 | Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†breakdown → | 559 |
| 18 | Detección precoz del carcinoma hepatocelular en pacientes cirróticos | 0 |
| 19 | 212 | |
| 20 | 97 |
About Jordi Bruix
Jordi Bruix is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 380 papers that have together received 75.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (266 papers), Liver Disease Diagnosis and Treatment (162 papers) and Liver Disease and Transplantation (74 papers). The work is most often cited by research in Hepatology (56.4k citations), Epidemiology (34.0k citations) and Cancer Research (12.7k citations). Jordi Bruix has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Josep M. Llovet, Morris Sherman, Alejandro Forner, María Reig, Concepció Brú, Andrew K. Burroughs, Carmen Ayuso, Josep Fuster, Vincenzo Mazzaferro and María Sala. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.